SP-1-activated LINC01016 overexpression promotes gastric cancer invasion and metastasis through inhibiting EIF4A3-mediated MMP9 mRNA decay

Abstract Long noncoding RNAs (lncRNAs) are key regulators during gastric cancer (GC) development and may be viable treatment targets. In the present study, we showed that the expression of the long intergenic noncoding RNA 01016 (LINC01016) is significantly higher in GC tissues with lymph node metas...

Full description

Saved in:
Bibliographic Details
Main Authors: Ying Sun, Hui Zhang, Duan-bo Shi, Peng Gao
Format: Article
Language:English
Published: Nature Publishing Group 2025-01-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-024-07250-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571219628523520
author Ying Sun
Hui Zhang
Duan-bo Shi
Peng Gao
author_facet Ying Sun
Hui Zhang
Duan-bo Shi
Peng Gao
author_sort Ying Sun
collection DOAJ
description Abstract Long noncoding RNAs (lncRNAs) are key regulators during gastric cancer (GC) development and may be viable treatment targets. In the present study, we showed that the expression of the long intergenic noncoding RNA 01016 (LINC01016) is significantly higher in GC tissues with lymph node metastasis (LNM) than those without LNM. LINC01016 overexpression predicts a poorer relapse-free survival (RFS) and overall survival (OS). Furthermore, we found that LINC01016 is activated by transcriptional factor SP-1 and contributes to the overt promotion of cell migratory ability. EIF4A3 was identified as a binding partner of LINC01016 by RNA pull-down assay, mass spectrometry and western blot. We determined that LINC01016 can blocks the binding of EIF4A3 to MMP9 mRNA, thereby inhibiting EIF4A3-mediated nonsense-mediated RNA decay (NMD), increasing MMP9 mRNA level and protein expression levels to promote tumor progression. LINC01016 or LINC01016-mediated EIF4A3/MMP9 may be potential therapeutic targets for patients with GC.
format Article
id doaj-art-1f26a8b1bb1a493d803e3658eb3dcde6
institution Kabale University
issn 2041-4889
language English
publishDate 2025-01-01
publisher Nature Publishing Group
record_format Article
series Cell Death and Disease
spelling doaj-art-1f26a8b1bb1a493d803e3658eb3dcde62025-02-02T12:44:51ZengNature Publishing GroupCell Death and Disease2041-48892025-01-0116111310.1038/s41419-024-07250-zSP-1-activated LINC01016 overexpression promotes gastric cancer invasion and metastasis through inhibiting EIF4A3-mediated MMP9 mRNA decayYing Sun0Hui Zhang1Duan-bo Shi2Peng Gao3Department of Pathology, Qilu Hospital and School of Basic Medical Sciences Shandong UniversityDepartment of Pathology, Qilu Hospital and School of Basic Medical Sciences Shandong UniversityDepartment of Pathology, Qilu Hospital and School of Basic Medical Sciences Shandong UniversityDepartment of Pathology, Qilu Hospital and School of Basic Medical Sciences Shandong UniversityAbstract Long noncoding RNAs (lncRNAs) are key regulators during gastric cancer (GC) development and may be viable treatment targets. In the present study, we showed that the expression of the long intergenic noncoding RNA 01016 (LINC01016) is significantly higher in GC tissues with lymph node metastasis (LNM) than those without LNM. LINC01016 overexpression predicts a poorer relapse-free survival (RFS) and overall survival (OS). Furthermore, we found that LINC01016 is activated by transcriptional factor SP-1 and contributes to the overt promotion of cell migratory ability. EIF4A3 was identified as a binding partner of LINC01016 by RNA pull-down assay, mass spectrometry and western blot. We determined that LINC01016 can blocks the binding of EIF4A3 to MMP9 mRNA, thereby inhibiting EIF4A3-mediated nonsense-mediated RNA decay (NMD), increasing MMP9 mRNA level and protein expression levels to promote tumor progression. LINC01016 or LINC01016-mediated EIF4A3/MMP9 may be potential therapeutic targets for patients with GC.https://doi.org/10.1038/s41419-024-07250-z
spellingShingle Ying Sun
Hui Zhang
Duan-bo Shi
Peng Gao
SP-1-activated LINC01016 overexpression promotes gastric cancer invasion and metastasis through inhibiting EIF4A3-mediated MMP9 mRNA decay
Cell Death and Disease
title SP-1-activated LINC01016 overexpression promotes gastric cancer invasion and metastasis through inhibiting EIF4A3-mediated MMP9 mRNA decay
title_full SP-1-activated LINC01016 overexpression promotes gastric cancer invasion and metastasis through inhibiting EIF4A3-mediated MMP9 mRNA decay
title_fullStr SP-1-activated LINC01016 overexpression promotes gastric cancer invasion and metastasis through inhibiting EIF4A3-mediated MMP9 mRNA decay
title_full_unstemmed SP-1-activated LINC01016 overexpression promotes gastric cancer invasion and metastasis through inhibiting EIF4A3-mediated MMP9 mRNA decay
title_short SP-1-activated LINC01016 overexpression promotes gastric cancer invasion and metastasis through inhibiting EIF4A3-mediated MMP9 mRNA decay
title_sort sp 1 activated linc01016 overexpression promotes gastric cancer invasion and metastasis through inhibiting eif4a3 mediated mmp9 mrna decay
url https://doi.org/10.1038/s41419-024-07250-z
work_keys_str_mv AT yingsun sp1activatedlinc01016overexpressionpromotesgastriccancerinvasionandmetastasisthroughinhibitingeif4a3mediatedmmp9mrnadecay
AT huizhang sp1activatedlinc01016overexpressionpromotesgastriccancerinvasionandmetastasisthroughinhibitingeif4a3mediatedmmp9mrnadecay
AT duanboshi sp1activatedlinc01016overexpressionpromotesgastriccancerinvasionandmetastasisthroughinhibitingeif4a3mediatedmmp9mrnadecay
AT penggao sp1activatedlinc01016overexpressionpromotesgastriccancerinvasionandmetastasisthroughinhibitingeif4a3mediatedmmp9mrnadecay